Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma. (Q53297754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

14

Philippe Moreau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Aline Clavert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Steven Le Gouill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Eolia Brissot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Viviane Dubruille

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Beatrice Mahe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Thomas Gastinne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nicolas Blin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Patrice Chevallier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Thierry Guillaume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jacques Delaunay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sameh Ayari

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Beatrice Saulquin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anne Moreau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jean-Luc Harousseau

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mohamad Mohty

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1502-1508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin’s Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.497981

10.3109/10428194.2010.497981

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20583964%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference